Resonance Health Limited (ASX:RHT)
Australia · Delayed Price · Currency is AUD 0.0590
-0.0030 (-4.84%)
Sep 9, 2026, 3:39 PM AEST
Resonance Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 15.75 | 11.07 | 8.59 | 4.4 | 3.83 |
Other Revenue | - | - | - | - | 0.03 |
| 15.75 | 11.07 | 8.59 | 4.4 | 3.85 | |
Revenue Growth | 42.25% | 28.91% | 95.02% | 14.31% | 1.96% |
Cost of Revenue | 0.54 | 0.36 | - | - | - |
Gross Profit | 15.21 | 10.71 | 8.59 | 4.4 | 3.85 |
Selling, General & Admin | 11.83 | 10.32 | 7.37 | 4.19 | 3.76 |
Research & Development | 0.43 | 0.96 | 0.84 | 0.71 | 0.72 |
Amortization of Goodwill & Intangibles | 0.49 | 0.52 | 0.26 | 0.3 | 0.31 |
Other Operating Expenses | 0.15 | 0.01 | 0.42 | 0.43 | 0.47 |
Operating Expenses | 13.37 | 12.26 | 9.12 | 5.76 | 5.38 |
Operating Income | 1.84 | -1.54 | -0.53 | -1.36 | -1.52 |
Interest Expense | -0.34 | -0.32 | -0.05 | - | - |
Interest & Investment Income | 0.02 | 0.04 | 0.14 | 0.04 | 0 |
Currency Exchange Gain (Loss) | -0.11 | 0.04 | 0.04 | 0.29 | 0.19 |
Other Non Operating Income (Expenses) | -0.31 | -0.34 | -0.23 | -0.2 | -0.22 |
EBT Excluding Unusual Items | 1.1 | -2.12 | -0.63 | -1.23 | -1.55 |
Gain (Loss) on Sale of Assets | - | -0.08 | - | - | - |
Asset Writedown | - | - | - | -0.03 | - |
Pretax Income | 1.1 | -2.2 | -0.63 | -1.26 | -1.55 |
Income Tax Expense | -0.41 | -0.47 | -0.8 | -0.48 | -0.41 |
Net Income | 1.51 | -1.73 | 0.17 | -0.78 | -1.14 |
Net Income to Common | 1.51 | -1.73 | 0.17 | -0.78 | -1.14 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 473 | 455 | 456 | 461 | 461 |
Shares Outstanding (Diluted) | 484 | 455 | 468 | 461 | 461 |
Shares Change | 6.28% | -2.81% | 1.59% | - | 1.97% |
EPS (Basic) | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
EPS (Diluted) | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 2.79 | 0.81 | 1.16 | -0.45 | -1.57 |
Free Cash Flow Per Share | 0.01 | 0.00 | 0.00 | -0.00 | -0.00 |
Gross Margin | 96.58% | 96.74% | 100.00% | 100.00% | 100.00% |
Operating Margin | 11.69% | -13.95% | -6.16% | -30.89% | -39.57% |
Profit Margin | 9.61% | -15.65% | 1.97% | -17.72% | -29.63% |
Free Cash Flow Margin | 17.69% | 7.27% | 13.48% | -10.11% | -40.86% |
EBITDA | 2.3 | -1.08 | -0.41 | -1.32 | -1.49 |
EBITDA Margin | 14.59% | -9.77% | -4.77% | -29.96% | -38.69% |
D&A For EBITDA | 0.46 | 0.46 | 0.12 | 0.04 | 0.03 |
EBIT | 1.84 | -1.54 | -0.53 | -1.36 | -1.52 |
EBIT Margin | 11.69% | -13.95% | -6.16% | -30.89% | -39.57% |